Comparative Effectiveness Research and Personalized Medicine: Catalyzing or Colliding?

Author： Epstein Robert S.   Teagarden J. Russell  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.10, 2010-10, pp. : 905-913

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative effectiveness research: what future in the US?

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 583, 2009-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Comparative Effectiveness, Personalized Medicine and Innovation: The Path Forward

By Thomas Adrian  

PharmacoEconomics, Vol. 28, Iss. 10, 2010-10 ,pp. : 923-930

Adis International

Access to resources Recommend Favorite

Regulatory Benefit-Risk Assessment and Comparative Effectiveness Research: Strangers, Bedfellows or Strange Bedfellows?

By GarrisonJr Louis P.  

PharmacoEconomics, Vol. 28, Iss. 10, 2010-10 ,pp. : 855-865

Adis International

Access to resources Recommend Favorite

Comparative Effectiveness Research: Improving Patient Care or Drug Rationing?

By Chou Roger  

Drugs, Vol. 71, Iss. 4, 2011-03 ,pp. : 383-386

Adis International

Access to resources Recommend Favorite

Prioritizing Comparative Effectiveness Research: Are Drug and Implementation Trials Equally Worth Funding?

By Gandjour Afschin  

PharmacoEconomics, Vol. 29, Iss. 7, 2011-07 ,pp. : 555-561

Adis International

Access to resources Recommend Favorite